Structured self‐monitoring of blood glucose regimens improve glycemic control in poorly controlled Chinese patients on insulin therapy: Results from COMPASS

Ji, Linong; Su, Qing; Feng, Bo; Shan, Zhongyan; Hu, Renming; Xing, Xiaoping; Xue, Yan; Yang, Tao; Hua, Yanyin

doi:10.1111/1753-0407.12434

Cited by 15 publications

(17 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The high out‐of‐pocket cost related to SMBG also contributes to poor performance of blood glucose monitoring. Finally, there is a severe shortage of personnel for teaching patients the self‐management skills for insulin injection and titration, which results in poor or no self‐titration of insulin . Accordingly, efforts to improve these issues are urgently needed to achieve timely insulin initiation and adherence, as well as appropriate dose titration in Chinese T2DM patients.…”

Section: Discussionmentioning

confidence: 99%

Observational Registry of Basal Insulin Treatment (ORBIT) in patients with type 2 diabetes uncontrolled with oral antihyperglycaemic drugs: Real‐life use of basal insulin in China

Zhang

Zhu

et al. 2017

Diabetes Obesity Metabolism

Self Cite

View full text Add to dashboard Cite

Aims: To examine treatment patterns following basal insulin (BI) introduction in type 2 diabetes mellitus (T2DM) patients under real-world conditions across China. Materials and methods:Overall, 18 995 patients inadequately controlled (HbA1c ≥ 53 mmol/ mol [7%]) with oral antihyperglycaemic drugs (OADs) and willing to receive BI treatment were registered at 209 hospitals and followed at baseline (visit 1), 3 months (visit 2) and 6 months (visit 3). Type of BI was initiated at physicians' discretion.Results: Retention with BI therapy at 6 months was 75.6%. Use of long-acting BI predominated, with insulin glargine accounting for 71%, detemir 13% and Neutral Protamine Hagedorn (NPH) insulin 16%. Over 70% of long-acting users maintained the same initial BI at visit 3, while 40% of NPH users switched treatment and 24.4% of participants initiated BI with prandial insulin. The initial mean (AE SD) dose of BI and total insulin was 0.18 AE 0.07 and 0.25 AE 0.19 IU/ kg, respectively, with a mean increase of daily dose by 0.03 and 0.02 IU/kg after 6 months, respectively. Only 56.6% of insulin users reported dose titration at visit 3. Mean HbA1c was 81 mmol/mol (9.6%) at baseline and 57 mmol/mol (7.4%) at 6 months. The frequency of hypoglycaemia was 1.61 and 2.07 episodes/patient-year at baseline and 6 months, respectively. Conclusions:In real-world clinical settings, add-on BI therapy in T2DM patients is associated with significant improvement in glycaemic control without overtly compromising safety related to hypoglycaemia and weight gain. Evolution of insulin treatment regimens varied among patients, but dose titration was suboptimal. More active BI dose titration might further improve glycaemic outcome in patients receiving BI therapy.

show abstract

Section: Discussionmentioning

confidence: 99%

Observational Registry of Basal Insulin Treatment (ORBIT) in patients with type 2 diabetes uncontrolled with oral antihyperglycaemic drugs: Real‐life use of basal insulin in China

Zhang

Zhu

et al. 2017

Diabetes Obesity Metabolism

Self Cite

View full text Add to dashboard Cite

show abstract

“…Self‐monitoring of blood glucose provides real‐time glucose measurements for the adjustment of insulin doses and diet and exercise regimens, and thus plays a critical part in diabetes management of insulin‐treated and non‐insulin‐treated patients . Moreover, SMBG can offer direct and intuitive feedback from patients’ lifestyle.…”

Section: Discussionmentioning

confidence: 99%

“…Self-monitoring of blood glucose provides real-time glucose measurements for the adjustment of insulin doses and diet and exercise regimens, and thus plays a critical part in diabetes management of insulin-treated and non-insulin-treated patients. [32][33][34] Moreover, SMBG can offer direct and intuitive feedback from patients' lifestyle. In the present study, the rate of good glycemic control for patients in the SMBG group was higher than in the no-SMBG group when the effect of educational attainment was ignored (64.01% vs 53.92%, respectively; P = 0.009), which is consistent with most previous studies.…”

Section: Discussionmentioning

confidence: 99%

Educational disparities in the associations between self‐monitoring of blood glucose and glycemic control in type 2 diabetes patients inXiamen,China

Zeng

et al. 2018

Journal of Diabetes

View full text Add to dashboard Cite

show abstract

“…SMBG not only adds value but is crucial in patients especially on the complex insulin regimens. It ensures safety and efficacy of the insulin regimens [41,42,[72][73][74].…”

Section: In Type 2 Dm Patients On Insulin Therapymentioning

confidence: 99%

RSSDI consensus on self-monitoring of blood glucose in types 1 and 2 diabetes mellitus in India

P¹,

Makkar

Kumar

et al. 2018

Int J Diabetes Dev Ctries

View full text Add to dashboard Cite

Maintaining a good glycemic control is crucial in the management of diabetes mellitus (DM) as it is associated with the reduction in both macro and microvascular complications of the disease. Self-monitoring of blood glucose (SMBG), which provides the day-today blood glucose levels, is a simple and practical tool for maintaining a good glycemic control. Although SMBG is widely practiced in other countries, its use in India is very limited. Even when used, it is not carried out is a structured manner. There seems to be a lack of education about the purpose of SMBG and the correct process and schedule to be followed. This highlights the unmet need for country-specific SMBG recommendations. In order to fulfil this need, a panel of expert endocrinologists/ diabetologists came together under the aegis of Research Society for the Study of Diabetes in India (RSSDI). They reviewed the current literature, combined the evidences with their clinical knowledge and expertise, and developed consensus recommendations for SMBG practice in India. This document provides a comprehensive review of the current literature on SMBG and presents the recommendations made by the expert panel.

show abstract

Structured self‐monitoring of blood glucose regimens improve glycemic control in poorly controlled Chinese patients on insulin therapy: Results from COMPASS

Abstract: A structured SMBG regimen, with training on interpretation of and responses to SMBG readings, increased SMBG frequency and improved HbA1c and the management of insulin-treated T2DM.

Cited by 15 publications

References 26 publications

Observational Registry of Basal Insulin Treatment (ORBIT) in patients with type 2 diabetes uncontrolled with oral antihyperglycaemic drugs: Real‐life use of basal insulin in China

Observational Registry of Basal Insulin Treatment (ORBIT) in patients with type 2 diabetes uncontrolled with oral antihyperglycaemic drugs: Real‐life use of basal insulin in China

Educational disparities in the associations between self‐monitoring of blood glucose and glycemic control in type 2 diabetes patients inXiamen,China

RSSDI consensus on self-monitoring of blood glucose in types 1 and 2 diabetes mellitus in India

Contact Info

Product

Resources

About